Literature DB >> 23175388

The many facets of MLL1 regulation.

Pamela Zhang1, Elisa Bergamin, Jean-François Couture.   

Abstract

In the last 20 years, we have witnessed an exponential number of evidences linking the human mixed lineage leukemia-1 (MLL1) gene to several acute and myelogenous leukemias. MLL1 is one of the founding members of the SET1 family of lysine methyltransferases and is key for the proper control of developmentally regulated gene expression. MLL1 is a structurally complex protein composed of several functional domains. These domains play pivotal roles for the recruitment of regulatory proteins. These MLL1 regulatory proteins (MRPs) dynamically interact with MLL1 and consequently control gene expression. In this review, we summarize recent structural and functional studies of MRPs and discuss emergent structural paradigms for the control of MLL1 activity.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23175388     DOI: 10.1002/bip.22126

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  12 in total

1.  Analysis of Mll1 deficiency identifies neurogenic transcriptional modules and Brn4 as a factor for direct astrocyte-to-neuron reprogramming.

Authors:  Matthew B Potts; Jason J Siu; James D Price; Ryan D Salinas; Mathew J Cho; Alexander D Ramos; Junghyun Hahn; Marta Margeta; Michael C Oldham; Daniel A Lim
Journal:  Neurosurgery       Date:  2014-10       Impact factor: 4.654

2.  Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome.

Authors:  Nicolas Lebrun; Irina Giurgea; Alice Goldenberg; Anne Dieux; Alexandra Afenjar; Jamal Ghoumid; Bertrand Diebold; Léo Mietton; Audrey Briand-Suleau; Pierre Billuart; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

3.  ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation.

Authors:  Roberta Minotti; Anneli Andersson; Michael O Hottiger
Journal:  Mol Cell Biol       Date:  2015-07-06       Impact factor: 4.272

4.  Cancer: Mutant p53 and chromatin regulation.

Authors:  Carol Prives; Scott W Lowe
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

5.  RNA Sequencing and Pathway Analysis Identify Important Pathways Involved in Hypertrichosis and Intellectual Disability in Patients with Wiedemann-Steiner Syndrome.

Authors:  Léo Mietton; Nicolas Lebrun; Irina Giurgea; Alice Goldenberg; Benjamin Saintpierre; Juliette Hamroune; Alexandra Afenjar; Pierre Billuart; Thierry Bienvenu
Journal:  Neuromolecular Med       Date:  2018-07-16       Impact factor: 3.843

6.  Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.

Authors:  Ali Imran; Brandon S Moyer; Ashley J Canning; Dan Kalina; Thomas M Duncan; Kelsey J Moody; Aaron J Wolfe; Michael S Cosgrove; Liviu Movileanu
Journal:  Biochem J       Date:  2021-06-11       Impact factor: 3.766

7.  Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex.

Authors:  Sara Weirich; Srikanth Kudithipudi; Albert Jeltsch
Journal:  Mol Oncol       Date:  2017-03-10       Impact factor: 6.603

Review 8.  Targeting human SET1/MLL family of proteins.

Authors:  Masoud Vedadi; Levi Blazer; Mohammad S Eram; Dalia Barsyte-Lovejoy; Cheryl H Arrowsmith; Taraneh Hajian
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

9.  KMT2A regulates cervical cancer cell growth through targeting VDAC1.

Authors:  Changlin Zhang; Yijun Hua; Huijuan Qiu; Tianze Liu; Qian Long; Wei Liao; Jiehong Qiu; Nang Wang; Miao Chen; Dingbo Shi; Yue Yan; Chuanbo Xie; Wuguo Deng; Tian Li; Yizhuo Li
Journal:  Aging (Albany NY)       Date:  2020-05-21       Impact factor: 5.682

10.  KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.

Authors:  Changlin Zhang; Chen Song; Tianze Liu; Ranran Tang; Miao Chen; Fan Gao; Binyi Xiao; Ge Qin; Fen Shi; Wenbin Li; Yixin Li; Xiaoyan Fu; Dingbo Shi; Xiangsheng Xiao; Lan Kang; Wenlin Huang; Xiaojun Wu; Bing Tang; Wuguo Deng
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.